BRCA1 and pancreatic neoplasm: Pancreatic cancer screening can be considered for individuals with exocrine pancreatic cancer in one or more first- or second-degree relatives from the same side of the family as the identified pathogenic/likely pathogenic BRCA1/2 mutation.